These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 5065660

  • 1. Structure-activity relationships: nitrosoureas.
    Johnston TP.
    Cancer Chemother Rep 3; 1972 May; 3(1):50-1. PubMed ID: 5065660
    [No Abstract] [Full Text] [Related]

  • 2. Chemistry and structure-activity studies of the nitrosoureas.
    Montgomery JA.
    Cancer Treat Rep; 1976 Jun; 60(6):651-64. PubMed ID: 954007
    [Abstract] [Full Text] [Related]

  • 3. Comparison of mutagenicity, antitumor activity, and chemical properties of selected nitrosoureas and nitrosoamides.
    Brundrett RB, Colvin M, White EH, McKee J, Hartman PE, Brown DL.
    Cancer Res; 1979 Apr; 39(4):1328-33. PubMed ID: 421216
    [Abstract] [Full Text] [Related]

  • 4. The synthesis of potential anticancer agents. XXXVI. N-nitrosoureas. II. Haloalkyl derivatives.
    Johnston TP, McCaleb GS, Opliger PS, Montgomery JA.
    J Med Chem; 1966 Nov; 9(6):892-911. PubMed ID: 5972051
    [No Abstract] [Full Text] [Related]

  • 5. Contributions of nitrosoureas to cancer treatment.
    Mitchell EP, Schein PS.
    Cancer Treat Rep; 1986 Jan; 70(1):31-41. PubMed ID: 3002621
    [No Abstract] [Full Text] [Related]

  • 6. Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems.
    Johnston TP, Montgomery JA.
    Cancer Treat Rep; 1986 Jan; 70(1):13-30. PubMed ID: 2935250
    [No Abstract] [Full Text] [Related]

  • 7. [Antitumor effect of compounds synthesized in the Division of Synthetic Chemistry (V) (author's transl)].
    Miyahara M, Kamiya S, Nakadate M, Sueyoshi S, Tanno M, Miyahara M.
    Eisei Shikenjo Hokoku; 1981 Jan; 99():111-3. PubMed ID: 7332796
    [No Abstract] [Full Text] [Related]

  • 8. Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea.
    Tyrer DD, Kline I, Venditti JM, Goldin A.
    Cancer Res; 1967 May; 27(5):873-9. PubMed ID: 6025252
    [No Abstract] [Full Text] [Related]

  • 9. Success and failure in the treatment of solid tumors. 3. "Cure" of metastatic Lewis lung carcinoma with methyl-CCNU (NSC-95442) and surgery-chemotherapy.
    Mayo JG, Laster WR, Andrews CM, Schabel FM.
    Cancer Chemother Rep; 1972 Apr; 56(2):183-95. PubMed ID: 5043226
    [No Abstract] [Full Text] [Related]

  • 10. Studies on the chemotherapy of experimental brain tumors: evaluation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, vincristine, and 5-fluorouracil.
    Shapiro WR.
    J Natl Cancer Inst; 1971 Feb; 46(2):359-68. PubMed ID: 4256014
    [No Abstract] [Full Text] [Related]

  • 11. Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.
    Bray DA, DeVita VT, Adamson RH, Oliverio VT.
    Cancer Chemother Rep; 1971 Jun; 55(3):215-20. PubMed ID: 5115843
    [No Abstract] [Full Text] [Related]

  • 12. Biological activity of hydroxylated chloroethylnitrosoureas.
    Zeller WJ, Frühauf S, Chen G, Eisenbrand G, Lijinsky W.
    Cancer Res; 1989 Jun 15; 49(12):3267-70. PubMed ID: 2720679
    [Abstract] [Full Text] [Related]

  • 13. Effect of treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or cyclophosphamide on spleen colony-forming units and survival time of leukemic mice.
    Vadlamudi S, Waravdekar VS, Choudry JN, Goldin A.
    Cancer Res; 1968 Jul 15; 28(7):1242-9. PubMed ID: 5665982
    [No Abstract] [Full Text] [Related]

  • 14. Antitumor structure-activity relations. Nitrosoureas vs. L-1210 leukemia.
    Hansch C, Leo A, Schmidt C, Jow PY, Montgomery JA.
    J Med Chem; 1980 Oct 15; 23(10):1095-101. PubMed ID: 7420354
    [Abstract] [Full Text] [Related]

  • 15. 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and methotrexate (NSC-740) as combination therapy for advanced mouse leukemia L1210.
    Venditti JM, Kline I, Tyrer DD, Goldin A.
    Cancer Chemother Rep; 1965 Oct 15; 48():35-9. PubMed ID: 5834736
    [No Abstract] [Full Text] [Related]

  • 16. Nitrosoureas: 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962; BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC-79037; CCNU)--clinical brochure.
    Carter SK, Newman JW.
    Cancer Chemother Rep 3; 1968 Dec 15; 1(1):115-51. PubMed ID: 4917773
    [No Abstract] [Full Text] [Related]

  • 17. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. X.
    Kline I, Gang M, Tyrer DD, Venditti JM, Artis EW, Goldin A.
    Cancer Chemother Rep 2; 1972 Nov 15; 3(1):1-69. PubMed ID: 4660732
    [No Abstract] [Full Text] [Related]

  • 18. Topical lomustine in the treatment of psoriasis.
    Peck GL, Guss SB, Key DJ.
    Arch Dermatol; 1972 Aug 15; 106(2):172-6. PubMed ID: 4558698
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of advanced Hodgkin's disease with (1,3 bis (2-chloroethyl)-1-nitrosourea) BCNU.
    Young RC, DeVita VT, Serpick AA, Canellos GP.
    N Engl J Med; 1971 Aug 26; 285(9):475-9. PubMed ID: 5558887
    [No Abstract] [Full Text] [Related]

  • 20. Historical development and future promise of the nitrosoureas as anticancer agents.
    Schabel FM.
    Cancer Chemother Rep 3; 1973 May 26; 4(3):3-6. PubMed ID: 4584035
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.